Form D · Private Equity Fund
PCA Opportunities Fund 2023, L.P. - Series E (Life Sciences IV)
Greenwich, CT · CIK 0002006308
Offering snapshot reported Jan 3, 2025 · SEC filing
- Reported sold
- $34.4M Indefinite offering
- Investors reported
- 66 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- May 31, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 66
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 3, 2025 | Amendment | $34,415,000 | No comparison | 66 | SEC filing |
| Jan 3, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-501436
Source: Form D, filed Jan 3, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Todd Kesselman | Executive |
| Gina La Versa | Executive |
| Precision Capital 2023 Gp, L.P. | Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
C/O Precision Capital 2023 Gp, L.P. 170 Mason Street
Greenwich, CT, 06830
Greenwich, CT, 06830